Engineering a juxtamembrane-targeting CAR T-cell against mesothelin: a novel binder resilient to shed antigen for enhanced efficacy against ovarian and pancreatic cancer - Quiz - MDSpire

Engineering a juxtamembrane-targeting CAR T-cell against mesothelin: a novel binder resilient to shed antigen for enhanced efficacy against ovarian and pancreatic cancer

  • By

  • John Scholler

  • Ai Song

  • Mansi Deshmukh

  • Decheng Song

  • Khatuna Gabunia

  • Mei Ji

  • Shimin Liu

  • Ting-Jia Fan

  • Gayathri Gulendran

  • Carl H. June

  • Don L. Siegel

  • July 1, 2026

  • 0 min

Share

Original Source(s)

Engineering a juxtamembrane-targeting CAR T-cell against mesothelin: a novel binder resilient to shed antigen for enhanced efficacy against ovarian and pancreatic cancer

  • by John Scholler, Ai Song, Mansi Deshmukh, Decheng Song, Khatuna Gabunia, Mei Ji, Shimin Liu, Ting-Jia Fan, Gayathri Gulendran, Carl H. June, Don L. Siegel

  • July 1, 2026

Related Content

Comparison between germline and somatic loss-of-function RNF43 mutations reveals different genotype-phenotype associations and provides insights into the genetic mechanisms of colorectal tumourigenesis

Therapeutic inhibition of RAS in non-small cell lung cancer

Distinct trajectories of low anterior resection syndrome following ileostomy reversal